These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 240181)

  • 1. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.
    Schechter MD; Cook PG
    Psychopharmacologia; 1975 May; 42(2):185-93. PubMed ID: 240181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic nature of amphetamine-induced pecking in pigeons.
    Cheng HC; Bhatnagar RK; Long JP
    Eur J Pharmacol; 1975; 33(2):319-24. PubMed ID: 1237409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
    Goudie AJ; Atkinson J; West CR
    Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine in the anorexigenic effect of DITA; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Nov; 40(1):39-44. PubMed ID: 991928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice.
    Simon P; Hémet C; Ramassamy C; Costentin J
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):509-14. PubMed ID: 8998404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
    Nash JF; Yamamoto BK
    Brain Res; 1993 Nov; 627(1):1-8. PubMed ID: 7904885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DA in the stimulant effect of DITA in mice; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Jan; 35(1):29-34. PubMed ID: 1253826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal responses of the globus pallidus to systemic administration of d-amphetamine: investigation of the involvement of dopamine, norepinephrine, and serotonin.
    Bergstrom DA; Walters JR
    J Neurosci; 1981 Mar; 1(3):292-9. PubMed ID: 6114996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.
    Callahan PM; Appel JB; Cunningham KA
    Psychopharmacology (Berl); 1991; 103(1):50-5. PubMed ID: 2006243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new animal model for schizophrenia: interactions with adrenergic mechanisms.
    Borison RL; Diamond BI
    Biol Psychiatry; 1978 Apr; 13(2):217-25. PubMed ID: 208665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry.
    Cadoni C; Pinna A; Russi G; Consolo S; Di Chiara G
    Neuroscience; 1995 Apr; 65(4):1027-39. PubMed ID: 7617159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
    Barrett RJ; Caul WF; Smith R
    Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.